FAVORABLE SAFETY PROFILE OF TIRBANIBULIN 1% OINTMENT FOR ACTINIC KERATOSIS: POOLED RESULTS FROM TWO PHASE 3 STUDIES

被引：0
|
作者：
Du Jardin, Kristian Gaarn [1 ]
Schlesinger, Todd [2 ]
Bhatia, Neal [3 ]
Berman, Brian [4 ]
Padulles, Laura [5 ]
Cutler, David [6 ]
Lebwohl, Mark [7 ]
机构：
[1] Almirall, Global Med Affairs, Barcelona, Spain
[2] Clin Res Ctr Carolinas, Charleston, SC USA
[3] Therapeut Clin Res, San Diego, CA USA
[4] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA
[5] Almirall, Barcelona, Spain
[6] Athenex Inc, Buffalo, NY USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2022年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PW15
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of methyl-aminolevulinate cream activated by daylight in actinic keratosis: Two randomized, investigator blinded, controlled, phase 3 studies in Europe and Australia
    Szeimies, Rolf-Markus
    Basset-Seguin, Nicole
    Rubel, Diana M.
    Shumack, Stephen P.
    Kerrouche, Nabil
    Leclerc, Stephanie
    Lacour, Jean Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB214 - AB214
  • [32] Efficacy and safety of methyl aminolaevulinate cream activated by daylight in actinic keratosis: two randomized, investigator-blinded, controlled, phase 3 studies in Europe and Australia
    Szeimies, R. -M.
    Basset-Seguin, N.
    Rubel, D.
    Shumack, S.
    Leclerc, S.
    Kerrouche, N.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 76 - 76
  • [33] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [34] Pregabalin pharmacokinetics and safety in healthy volunteers: Results from two Phase 1 studies
    Bockbrader, HN
    Hunt, T
    Strand, J
    Posvar, E
    Sedman, A
    NEUROLOGY, 2000, 54 (07) : A421 - A421
  • [35] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RA
    Walker, David
    Winthrop, Kevin
    Genovese, Mark C.
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitiz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lie
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    RHEUMATOLOGY, 2020, 59
  • [36] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [37] SAFETY PROFILE OF BELATACEPT IN KIDNEY TRANSPLANT RECIPIENTS FROM A POOLED ANALYSIS OF PHASE II AND PHASE III STUDIES
    Grinyo, J.
    Charpentier, B.
    Medina Pestana, J.
    Vanrenterghem, Y.
    Vincenti, F.
    Shi, R.
    Agarwal, M.
    Thomas, D.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 60
  • [38] Safety Profile of Belatacept in Kidney Transplant Recipients from a Pooled Analysis of Phase II and Phase III Studies
    Grinyo, J.
    Charpentier, B.
    Pestana, J. Medina
    Vanrenterghem, Y.
    Vincenti, F.
    Shi, R.
    Agarwal, M.
    Thomas, D.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 83 - 83
  • [39] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [40] Efficacy and safety of methyl-aminolevulinate cream activated by daylight in actinic keratosis: Two randomized, investigator-blinded, controlled phase 3 studies in Europe and Australia
    Szeimies, Rolf-Markus
    Basset-Seguin, Nicole
    Rubel, Diana
    Shumack, Stephen
    Kerrouche, Nabil
    Kerob, Delphine
    Lacour, Jean Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB120 - AB120
12345